Related Articles
C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathway
Proteasome inhibitor bortezomib (PS-341) enhances RANKL-induced MDA-MB-231 breast cancer cell migration
Inhibition effects of total flavonoids from Sculellaria barbata D. Don on human breast carcinoma bone metastasis via downregulating PTHrP pathway
Caveolin‑1 enhances RANKL‑induced gastric cancer cell migration
Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro